(Q24240837)

1

0 references

Francine M Ducharme

6

object named as

Francine M Ducharme

0 references

Johan C de Jongste

5

object named as

Johan C de Jongste

0 references

author name string

Johannes HJM Uijen

2

0 references

Roos MD Bernsen

3

0 references

Marjolein JA Tasche

Cochrane Database of Systematic Reviews

4

0 references

publication date

8 October 2008

0 references

published in

0 references

cites work

Nebulised sodium cromoglycate in the treatment of wheezy bronchitis. A multicentre double-blind placebo controlled study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Nebulised sodium cromoglycate in recurrently wheezy preschool children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Controlled trial of cromoglycate and slow-release aminophylline in perennial childhood asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Efficacy of cromoglycate in persistently wheezing infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Nebulised sodium cromoglycate in the treatment of wheezy bronchitis in infants and young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Nebulised cromoglycate, theophylline, and placebo in preschool asthmatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Nebulised ipratropium bromide and sodium cromoglycate in the first two years of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Nebulized sodium cromoglycate in young asthmatic children. Double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Inhaled sodium cromoglycate for pre-term children with respiratory symptoms at follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Sleep quality in children with asthma treated with theophylline or cromolyn sodium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Immediate and late bronchial obstructive reactions to inhalation of house dust and protective effects of disodium cromoglycate and prednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Budesonide but not nedocromil sodium reduces exhaled nitric oxide levels in asthmatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Effect of sodium cromoglycate and nifedipine on adenosine-induced bronchoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Inhaled steroids compared with disodium cromoglycate in preschool children with episodic viral wheeze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

The place of cromolyn sodium in the long-term management of childhood asthma based on a 3- to 5-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Evaluation of Disodium Cromoglycate in Intrinsic and Extrinsic Asthma1–3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Role of Disodium Cromoglycate ('Intal') in Treatment of Childhood Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Effects of regular inhalation of beclomethasone dipropionate and sodium cromoglycate on bronchial hyperreactivity in asthmatic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Nebulised sodium cromoglycate in the preschool wheezy child

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Modification of bronchial hyperreactivity after treatment with sodium cromoglycate during pollen season

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Treatment of childhood asthma with sodium cromoglycate and beclomethasone dipropionate aerosol singly and in combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Betamethasone valerate compared with sodium cromoglycate in asthmatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Comparison of fluticasone propionate and sodium cromoglycate for the treatment of childhood asthma (an open parallel group study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Trial of Disodium Cromoglycate in Bronchial Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Clinical trial of disodium cromoglycate in treatment of asthma in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Skin thickness in children treated with daily or periodical inhaled budesonide for mild persistent asthma. The Helsinki early intervention childhood asthma study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

The effect of disodium cromoglycate against bronchial hyperresponsiveness in asthmatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

A double-blind trial of disodium cromoglycate in bronchial asthma wh assessment by four observers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Herbal interventions for chronic asthma in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Effectiveness of prophylactic inhaled steroids in childhood asthma: a systemic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

The efficacy of inhaled disodium cromoglycate and glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

A method for assessing the quality of a randomized control trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

21 January 2018

Misleading meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Meta-analyses involving cross-over trials: methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

The statistical basis of meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Statistical issues in a metaregression analysis of randomized trials: impact on the dietary sodium intake and blood pressure relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

House dust mite control measures for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Inhaled sodium cromoglycate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Nedocromil sodium vs. sodium cromoglycate for preventing exercise-induced bronchoconstriction in asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Adverse reactions to cromolyn sodium: patient report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Oral xanthines as maintenance treatment for asthma in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Cromolyn sodium: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Beclomethasone for asthma in children: effects on linear growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Nedocromil sodium for preventing exercise-induced bronchoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Nedocromil sodium for chronic asthma in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Sodium cromoglycate in childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Inhaled disodium cromoglycate (DSCG) as maintenance therapy in children with asthma: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Sodium cromoglycate for asthma in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

Inhaled beclomethasone versus placebo for chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

The effect of sodium cromoglycate on upper and lower respiratory symptoms in children born prematurely

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

A controlled study of cromolyn sodium sponsored by the Drug Committee of the American Academy of Allergy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

A multicenter evaluation of the clinical benefits of cromolyn sodium aerosol by metered-dose inhaler in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

Variance imputation for overviews of clinical trials with continuous response

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

Disodium cromoglycate in the control of asthma. A double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

Cromolyn therapy for severe asthma in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

Disodium chromoglycate in the treatment of allergic bronchial asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

Disodium cromoglycate in the treatment of bronchial asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

Randomised placebo-controlled trial of inhaled sodium cromoglycate in 1-4-year-old children with moderate asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

Twenty years of sodium cromoglycate treatment: a short review.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

New guidelines for diagnosis and management of asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

[Protective effect of ketotifen and disodium cromoglycate in bronchial challenge tests with allergens (author's transl)]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

Cromolyn sodium therapy in childhood asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

The effect of frequent administration of sodium cromoglycate to asthmatic children who previously responded poorly.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

A placebo-controlled trial of ketotifen (HC 20-511, Sandoz) in allergen induced asthma and comparison with disodium cromoglycate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

The management of bronchial asthma in children under the age of 3 1/2 years using Intal (sodium cromoglycate) administered by Spinhaler

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

Sodium cromoglycate (Intal) as an anti-inflammatory agent for the treatment of chronic asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

Disodium cromoglycate (intal) in the treatment of bronchial asthma in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

Death after cromoglycate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

A double-blind, placebo-controlled comparison of sodium cromoglycate and ketotifen in the treatment of childhood asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

Sodium cromoglycate as a replacement for inhaled corticosteroids in mild-to-moderate childhood asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

Sodium cromoglycate therapy in wheezing infants: preliminary evidence of beneficial outcome at early school age

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

Long-term trial of disodium cromoglycate and isoprenaline in children with asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

Long-term study of the protective effect of ketotifen in children with allergic bronchial asthma. The value of a provocation test in assessment of treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

Long-term treatment with disodium cromoglycate does not alter bronchial hyperreactivity in patients with perennial bronchial asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

Double blind single crossover clinical evaluation of disodium cromoglicate in bronchial asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

Cromolyn sodium prophylaxis inhibits pulmonary proinflammatory cytokines in infants at high risk for bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

Clinical experiences with the use of cromolyn sodium in asthmatic children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

Comparison of 1 mg and 5 mg sodium cromoglycate metered dose inhalers in the treatment of asthma: a 12-week double-blind, parallel group trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

Controlled trial of two formulations of cromolyn sodium in the treatment of asthmatic patients > or = 12 years of age. Intal Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

Short- and long-term prophylaxis with cromolyn sodium in chronic asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

Bronchial response to methacholine in "healthy" children of asthmatic parents. Effect of treatment with cromolyn sodium

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

Bronchial Asthma Treated with Cromolyn Sodium: A Double-Blind Crossover Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021

Cromolyn therapy in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002173.PUB2

7 January 2021